Global Head and Neck Cancer Therapeutics Market Size, Status and Forecast 2019-2025

Published On: Jun 2019

Format: PDF

Publisher: QY Research

Pages: 91

Report ID: 1129

Head and neck cancer is a group of cancers that starts in the mouth, nose, throat, larynx, sinuses, or salivary glands.

Current trends indicate that rising geriatric population worldwide, growing cases of target diseases, and availability of improved healthcare services due to government and private organization initiatives will drive the overall market.
In 2018, the global Head and Neck Cancer Therapeutics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Head and Neck Cancer Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Head and Neck Cancer Therapeutics development in United States, Europe and China.

The key players covered in this study
Sanofi
Eli Lilly
Amgen
Actavis
Dr. Reddy’s Laboratories
Jiangsu Hengrui
Teva Pharmaceutical
DFG
BioXpress

Market segment by Type, the product can be split into
PD Inhibitors
Microtubule Inhibitors
EGFR Inhibitors

Market segment by Application, split into
Surgery
Radiation therapy
Chemotherapy
Immunotherapy

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Head and Neck Cancer Therapeutics status, future forecast, growth opportunity, key market and key players.
To present the Head and Neck Cancer Therapeutics development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Head and Neck Cancer Therapeutics are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Head and Neck Cancer Therapeutics Market Size Growth Rate by Type (2014-2025)
1.4.2 PD Inhibitors
1.4.3 Microtubule Inhibitors
1.4.4 EGFR Inhibitors
1.5 Market by Application
1.5.1 Global Head and Neck Cancer Therapeutics Market Share by Application (2014-2025)
1.5.2 Surgery
1.5.3 Radiation therapy
1.5.4 Chemotherapy
1.5.5 Immunotherapy
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Head and Neck Cancer Therapeutics Market Size
2.2 Head and Neck Cancer Therapeutics Growth Trends by Regions
2.2.1 Head and Neck Cancer Therapeutics Market Size by Regions (2014-2025)
2.2.2 Head and Neck Cancer Therapeutics Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Head and Neck Cancer Therapeutics Market Size by Manufacturers
3.1.1 Global Head and Neck Cancer Therapeutics Revenue by Manufacturers (2014-2019)
3.1.2 Global Head and Neck Cancer Therapeutics Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Head and Neck Cancer Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2 Head and Neck Cancer Therapeutics Key Players Head office and Area Served
3.3 Key Players Head and Neck Cancer Therapeutics Product/Solution/Service
3.4 Date of Enter into Head and Neck Cancer Therapeutics Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Head and Neck Cancer Therapeutics Market Size by Type (2014-2019)
4.2 Global Head and Neck Cancer Therapeutics Market Size by Application (2014-2019)

5 United States
5.1 United States Head and Neck Cancer Therapeutics Market Size (2014-2019)
5.2 Head and Neck Cancer Therapeutics Key Players in United States
5.3 United States Head and Neck Cancer Therapeutics Market Size by Type
5.4 United States Head and Neck Cancer Therapeutics Market Size by Application

6 Europe
6.1 Europe Head and Neck Cancer Therapeutics Market Size (2014-2019)
6.2 Head and Neck Cancer Therapeutics Key Players in Europe
6.3 Europe Head and Neck Cancer Therapeutics Market Size by Type
6.4 Europe Head and Neck Cancer Therapeutics Market Size by Application

7 China
7.1 China Head and Neck Cancer Therapeutics Market Size (2014-2019)
7.2 Head and Neck Cancer Therapeutics Key Players in China
7.3 China Head and Neck Cancer Therapeutics Market Size by Type
7.4 China Head and Neck Cancer Therapeutics Market Size by Application

8 Japan
8.1 Japan Head and Neck Cancer Therapeutics Market Size (2014-2019)
8.2 Head and Neck Cancer Therapeutics Key Players in Japan
8.3 Japan Head and Neck Cancer Therapeutics Market Size by Type
8.4 Japan Head and Neck Cancer Therapeutics Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Head and Neck Cancer Therapeutics Market Size (2014-2019)
9.2 Head and Neck Cancer Therapeutics Key Players in Southeast Asia
9.3 Southeast Asia Head and Neck Cancer Therapeutics Market Size by Type
9.4 Southeast Asia Head and Neck Cancer Therapeutics Market Size by Application

10 India
10.1 India Head and Neck Cancer Therapeutics Market Size (2014-2019)
10.2 Head and Neck Cancer Therapeutics Key Players in India
10.3 India Head and Neck Cancer Therapeutics Market Size by Type
10.4 India Head and Neck Cancer Therapeutics Market Size by Application

11 Central & South America
11.1 Central & South America Head and Neck Cancer Therapeutics Market Size (2014-2019)
11.2 Head and Neck Cancer Therapeutics Key Players in Central & South America
11.3 Central & South America Head and Neck Cancer Therapeutics Market Size by Type
11.4 Central & South America Head and Neck Cancer Therapeutics Market Size by Application

12 International Players Profiles
12.1 Sanofi
12.1.1 Sanofi Company Details
12.1.2 Company Description and Business Overview
12.1.3 Head and Neck Cancer Therapeutics Introduction
12.1.4 Sanofi Revenue in Head and Neck Cancer Therapeutics Business (2014-2019)
12.1.5 Sanofi Recent Development
12.2 Eli Lilly
12.2.1 Eli Lilly Company Details
12.2.2 Company Description and Business Overview
12.2.3 Head and Neck Cancer Therapeutics Introduction
12.2.4 Eli Lilly Revenue in Head and Neck Cancer Therapeutics Business (2014-2019)
12.2.5 Eli Lilly Recent Development
12.3 Amgen
12.3.1 Amgen Company Details
12.3.2 Company Description and Business Overview
12.3.3 Head and Neck Cancer Therapeutics Introduction
12.3.4 Amgen Revenue in Head and Neck Cancer Therapeutics Business (2014-2019)
12.3.5 Amgen Recent Development
12.4 Actavis
12.4.1 Actavis Company Details
12.4.2 Company Description and Business Overview
12.4.3 Head and Neck Cancer Therapeutics Introduction
12.4.4 Actavis Revenue in Head and Neck Cancer Therapeutics Business (2014-2019)
12.4.5 Actavis Recent Development
12.5 Dr. Reddy’s Laboratories
12.5.1 Dr. Reddy’s Laboratories Company Details
12.5.2 Company Description and Business Overview
12.5.3 Head and Neck Cancer Therapeutics Introduction
12.5.4 Dr. Reddy’s Laboratories Revenue in Head and Neck Cancer Therapeutics Business (2014-2019)
12.5.5 Dr. Reddy’s Laboratories Recent Development
12.6 Jiangsu Hengrui
12.6.1 Jiangsu Hengrui Company Details
12.6.2 Company Description and Business Overview
12.6.3 Head and Neck Cancer Therapeutics Introduction
12.6.4 Jiangsu Hengrui Revenue in Head and Neck Cancer Therapeutics Business (2014-2019)
12.6.5 Jiangsu Hengrui Recent Development
12.7 Teva Pharmaceutical
12.7.1 Teva Pharmaceutical Company Details
12.7.2 Company Description and Business Overview
12.7.3 Head and Neck Cancer Therapeutics Introduction
12.7.4 Teva Pharmaceutical Revenue in Head and Neck Cancer Therapeutics Business (2014-2019)
12.7.5 Teva Pharmaceutical Recent Development
12.8 DFG
12.8.1 DFG Company Details
12.8.2 Company Description and Business Overview
12.8.3 Head and Neck Cancer Therapeutics Introduction
12.8.4 DFG Revenue in Head and Neck Cancer Therapeutics Business (2014-2019)
12.8.5 DFG Recent Development
12.9 BioXpress
12.9.1 BioXpress Company Details
12.9.2 Company Description and Business Overview
12.9.3 Head and Neck Cancer Therapeutics Introduction
12.9.4 BioXpress Revenue in Head and Neck Cancer Therapeutics Business (2014-2019)
12.9.5 BioXpress Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details